Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18650
According to the market research study by Transparency Market Research, in 2016, the global market for NASH biomarkers was worth US1.2 mn and is projected to reach a value of US.7 bn by the end of 2024. The market is estimated to register a whopping 31.70% CAGR between 2016 and 2024.
Presence of Leading Players to Drive Europe NASH Biomarkers Market
The global market for NASH biomarkers has been categorized on the basis of geography into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific. Among these, Europe is anticipated to lead the global market and account for a large share of the market throughout the forecast period. The high growth of this region can be attributed to the presence of the leading players. In addition to this, the increasing pool of patients who are suffering from NAFLD and NASH are some of the other factors that are predicted to enhance the growth of the Europe market in the coming few years. Furthermore, Asia Pacific is likely to register a strong growth rate in the next few years.
In terms of product type, the global NASH biomarkers market has been categorized apoptosis biomarkers, hepatic fibrosis biomarkers, into serum biomarkers, and oxidative stress biomarkers. Among these, hepatic biomarkers and serum biomarkers are used extensively in the medical field, further encouraging the growth of the overall market in the near future. The ability to provide efficient results is one of the major factors, which is estimated to encourage the growth of the serum biomarkers market in the next few years.
Rising Type 2 Diabetes to Support Growth of Global NASH Biomarkers Market
The increasing prevalence of non-alcoholic liver diseases is considered as one of the major factors anticipated to accelerate the growth of the global NASH biomarkers market in the next few years. The rising number of patients with type 2 diabetes is another key factor that is likely to accelerate the growth of the global market in the next few years. Furthermore, the rising focus on the research and development activities and innovations and advancements are predicted to create potential growth opportunities for the market players in the next few years. In addition to this, the rapid development of the healthcare sector is another key factor that is predicted to enhance the growth of the overall market in the coming years.
This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Non-alcoholic Steatohepatitis (NASH) Biomarkers Market (Marker Type – Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, and Oxidative Stress Biomarkers; End User – Contract Research Organizations (CRO) and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
